Order Article Reprints

Trovini G, Lombardozzi G, Kotzalidis GD, Lionetto L, Russo F, Sabatino A, Serra E, Castorina S, Civita G, Frezza S, et al. Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels. International Journal of Molecular Sciences. 2025; 26(3):1394. https://doi.org/10.3390/ijms26031394

Trovini, Giada, Ginevra Lombardozzi, Georgios D. Kotzalidis, Luana Lionetto, Felicia Russo, Angela Sabatino, Elio Serra, Simone Castorina, Giorgia Civita, Sara Frezza, and et al. 2025. "Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels" International Journal of Molecular Sciences 26, no. 3: 1394. https://doi.org/10.3390/ijms26031394

Trovini, G., Lombardozzi, G., Kotzalidis, G. D., Lionetto, L., Russo, F., Sabatino, A., Serra, E., Castorina, S., Civita, G., Frezza, S., De Bernardini, D., Costanzi, G., Alborghetti, M., Simmaco, M., Nicoletti, F., & De Filippis, S. (2025). Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels. International Journal of Molecular Sciences, 26(3), 1394. https://doi.org/10.3390/ijms26031394